Elamipretide Impurity 3 | CAS 2389-45-9 - Request Quote
Elamipretide Impurity 3
| SZ CAT No: | SZ-E152004 |
| CAS No | 2389-45-9 |
| Mol.F. | C19H28N2O6 |
| Mol.Wt. |
380.4 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Elamipretide Impurity 3 is chemically N6-((benzyloxy)carbonyl)-N2-(tert-butoxycarbonyl)-L-lysine. Elamipretide Impurity 3 is supplied with detailed characterization data compliant with regulatory guideline. Elamipretide Impurity 3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Elamipretide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2389-45-9
Purchase 2389-45-9
Order 2389-45-9
Enquire 2389-45-9
price of 2389-45-9
2389-45-9 Supplier
2389-45-9 Manufacturer
2389-45-9 Exporter
buy high quality Elamipretide Impurity 3
Purchase Elamipretide Impurity 3
Elamipretide Impurity 3 suppliers
Elamipretide Impurity 3 manufacturers
Elamipretide Impurity 3 price
Order Elamipretide Impurity 3
Enquire Elamipretide Impurity 3
Elamipretide Impurity 3 cost
Elamipretide Impurity 3 Supplier
Elamipretide Impurity 3 Distributor
Elamipretide Impurity 3 for Method Validation
Elamipretide Reference Standard
Elamipretide Impurity 3 for ANDA Filing
Elamipretide Impurity 3 for Forced Degradation Studies
Elamipretide Impurity 3 Identification Standards
Elamipretide Impurity 3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.